27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Seelos Therapeutics (NASDAQ:SEEL) shares traded higher after news emerged the company acquired the license of gene therapy program to address Parkinson's disease from Duke University.
The gene therapy program targets the regulation of the SNCA gene. Seelos plans to study this approach, named SLS-004, initially in Parkinson’s disease.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Seelos Therapeutics shares traded higher by 12.5% to $2.51 in Thursday's pre-market session.
Related Links:
Acer Therapeutics Shares Plunge On FDA Complete Response Letter
Pfizer Receives European Commission Approval For Breast Cancer Drug TALZENNA
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.